is ozempic a glp-1 More people with type 1 diabetes are using drugs, study finds, despite limited evidence on safety or effectiveness Medicare will negotiate Novo's GLP-1
Description
Caution when using GLP-1 RAs in older patients, especially those 75 years old, has been suggested to prevent the risk of sarcopenia

(8) Excess body weight increases the mechanical load on weight-bearing joints, accelerating cartilage wear and joint degeneration, and contributing to a pro-inflammatory state that further exacerbates joint damage

Subcutaneous GLP1Ra-based obesity treatment is expensive, net prices ranging from $717 to $761 per month, with further variations based on insurance coverage (Hernandez and Sullivan, 2024)

C.FleckP

10.1111/dom.12937 63 PratleyR

August 8, 2025
